Skip to main content
Signal8

Tyndall Mark Anthony

SEC insider (Form 3/4/5 filer). CIK 0001944622. EVP & CLO and Corp Sec at Keenova Therapeutics plc (NONE). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 25, 2026. Located in BRIDGEWATER, NJ.

Companies Tyndall Mark Anthony has filed insider reports for

  • Keenova Therapeutics plc (NONE): Officer, EVP & CLO and Corp Sec
Tyndall Mark Anthony profile photo

Tyndall Mark Anthony

CIK: 0001944622

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Keenova Therapeutics plc logo
NONE

Keenova Therapeutics plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Feb 25, 2026
    Award

    Restricted Stock Units

    Direct
    51.8K shares-
  • No ticker

    Keenova Therapeutics plc

    Jan 1, 2026
    Exercise
    Direct
    6.6K shares-
  • No ticker

    Keenova Therapeutics plc

    Jan 1, 2026
    Tax Payment
    Direct
    2.1K shares-
  • No ticker

    Mallinckrodt plc

    Jul 31, 2025
    Award

    Restricted Stock Units

    Direct
    32.8K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Exercise
    Direct
    5.5K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Tax Payment
    Direct
    1.8K shares-

1-6 of 6